Oh, D-Y: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study

Boku, N., Ryu, M.H., Oh, D-Y., Oh, S.C., Chung, H.C., Lee, K-W., Omori, T., Shitara, K., Sakuramoto, S., Chung, I.J., Yamaguchi, K., Kato, K., Sym, S.J., Kadowaki, S., Tsuji, K., Chen, J-S., Bai, L-Y.

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 83 KB

2020

2

Abstract: P685 4-1BB FACILITATES ATHEROSCLEROSIS VIA BIDIRECTIONAL ACTIVATION OF T CELL AND MONOCYTE/MACROPHAGE IN ATHEROGENIC MICE

Jung, IH, Jeon, HJ, Choi, J-H, Park, JG, Lee, MR, Lee, MN, Yoo, J-Y, Jeong, SJ, Kwon, BS, Kim, D-Y, Oh, GT

Journal:

Atherosclerosis Supplements

Year:

2009

Language:

english

File:

PDF, 94 KB

english, 2009

3

PROOF: A multicenter, open-label, randomized, phase III trial of infigratinib vs gemcitabine + cisplatin in patients with advanced cholangiocarcinoma with FGFR2 gene rearrangements

Abou-Alfa, G.K., Borbath, I., Cohn, A.L., Goyal, L., Lamarca, A., Macarulla, T., Oh, D-Y., Roychowdhury, S., Sadeghi, S., Shroff, R.T., Howland, M., Li, A., Cho, T., Pande, A., Javle, M.

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 104 KB

2020

4

Phase Ib/II study of ibrutinib (ibr) in combination with cetuximab (cetux) in patients (pts) with previously treated metastatic colorectal cancer (mCRC)

Oh, D-Y., Arkenau, T., Lee, K-W., Alsina, M., Marti, F.M., Chung, I.J., Saif, W., Wang, D., O'Dwyer, P., Chau, I., Lee, M-A., Chong, E., Hilger-Rolfe, J., Cole, G., Kim, S.Y.

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 80 KB

2020

5

Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals

Yun, H-M, Oh, J H, Shim, J-H, Ban, J O, Park, K-R, Kim, J-H, Lee, D H, Kang, J-W, Park, Y H, Yu, D, Kim, Y, Han, S B, Yoon, D-Y, Hong, J T

Journal:

Cell Death and Disease

Year:

2013

Language:

english

File:

PDF, 2.67 MB

english, 2013

6

Atypical Aeromonas salmonicida infection in the black rockfish, Sebastes schlegeli Hilgendorf, in Korea

H-J Han, D-Y Kim, W-S Kim, C-S Kim, S-J Jung, M-J Oh, D-H Kim

Journal:

Journal of Fish Diseases

Year:

2011

Language:

english

File:

PDF, 507 KB

english, 2011

7

Cytokeratin19 induced by HER2/ERK binds and stabilizes HER2 on cell membranes

Ju, J-h, Oh, S, Lee, K-m, Yang, W, Nam, K S, Moon, H-G, Noh, D-Y, Kim, C G, Park, G, Park, J B, Lee, T, Arteaga, C L, Shin, I

Journal:

Cell Death & Differentiation

Year:

2015

Language:

english

File:

PDF, 3.07 MB

english, 2015

8

789TiPHALO 109-301: Phase III, randomized, double-blind, placebo-controlled study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients with previously untreated hyaluronan (HA)-high stage IV pancreatic ductal adenocarcinoma (PDA)

Van Cutsem, E, Corrie, P G, Ducreux, M P, Sigal, D, Sahai, V, Oh, D-Y, Bullock, A, Bang, Y-J, Baron, A D, Hendifar, A, Li, C-P, Philip, P, Reni, M, Zalupski, M, Zheng, L, Berman, C, Chondros, D, Tempe

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 76 KB

2018

9

LBA40FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)

Vogel, A, Sahai, V, Hollebecque, A, Vaccaro, G, Melisi, D, Al-Rajabi, R, Paulson, A S, Borad, M J, Gallinson, D, Murphy, A G, Oh, D-Y, Dotan, E, Catenacci, D V, Van Cutsem, E, Lihou, C F, Zhen, H, Fél

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 78 KB

2019

10

675PDPOLO: Health-related quality of life (HRQoL) of olaparib maintenance treatment versus placebo in patients with a germline BRCA mutation and metastatic pancreatic cancer (mPC)

Hammel, P, Kindler, H L, Reni, M, Van Cutsem, E, Macarulla Mercade, T, Hall, M J, Park, J O, Hochhauser, D, Arnold, D, Oh, D-Y, Reinacher-Schick, A, Tortora, G, Algül, H, O’Reilly, E M, McGuinness, D,

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 90 KB

2019

11

Classification of segmental vitiligo on the face: clues for prognosis

D-Y. Kim, S.H. Oh, S-K. Hann

Journal:

British Journal of Dermatology

Year:

2011

Language:

english

File:

PDF, 335 KB

english, 2011

12

Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib

Hammel, P, Kindler, H L, Reni, M, Van Cutsem, E, Macarulla, T, Hall, M J, Park, J O, Hochhauser, D, Arnold, D, Oh, D-Y, Reinacher-Schick, A, Tortora, G, Algül, H, O’Reilly, E M, McGuinness, D, Cui, K

Journal:

Annals of Oncology

Year:

2019

Language:

english

File:

PDF, 1.81 MB

english, 2019

13

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

Han, S-W, Oh, D-Y, Im, S-A, Park, S R, Lee, K-W, Song, H S, Lee, N-S, Lee, K H, Choi, I S, Lee, M H

Journal:

British Journal of Cancer

Year:

2009

Language:

english

File:

PDF, 148 KB

english, 2009

14

260TiPPhase 3, randomized, double-blind, placebo-controlled study of PEGylated recombinant human hyaluronidase PH20 (PEGPH20)+nab-paclitaxel/gemcitabine in patients with previously untreated, hyaluronan-high, stage IV pancreatic ductal adenocarcinoma (PDA)

Oh, D-Y, Bang, Y-J, Van Cutsem, E, Hendifar, A, Reni, M, Zheng, L, Ducreux, M, Harris, W, Corrie, P, Seery, T, Chondros, D, Bullock, A, Li, C-P

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 58 KB

english, 2017

15

756PInterim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations

Hollebecque, A, Borad, M, Sahai, V, Catenacci, D V T, Murphy, A, Vaccaro, G, Paulson, A, Oh, D-Y, Féliz, L, Lihou, C, Zhen, H, Abou-Alfa, G K

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 79 KB

english, 2018

16

759PPhase II study of evofosfamide (TH-302) monotherapy as a second-line treatment in advanced biliary tract cancer

Yoon, J S, Lee, K-H, Cheon, G J, Bang, Y-J, Oh, D-Y

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 75 KB

2018

17

831TiPA phase III, randomized, double-blind, placebo-controlled, international study of durvalumab in combination with gemcitabine plus cisplatin for patients with advanced biliary tract cancers: TOPAZ-1

Oh, D-Y, Chen, L-T, He, A R, Okusaka, T, Qin, S, Chin, S, Rokutanda, N, Uchinda, H, Vogel, A, Valle, J W, Kim, H

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 76 KB

2019

18

832TiPInfigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomized, phase III study in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial

Abou-Alfa, G K, Borbath, I, Clarke, S J, Hitre, E, Louvet, C, Macarulla, T, Oh, D-Y, Spratlin, J L, Valle, J W, Weiss, K H, Berman, C, Howland, M, Ye, Y, Cho, T, Moran, S, Javle, M M

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 85 KB

2019

19

High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer

Kim, D-W, Min, H S, Lee, K-H, Kim, Y J, Oh, D-Y, Jeon, Y K, Lee, S-H, Im, S-A, Chung, D H, Kim, Y T

Journal:

British Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 249 KB

english, 2008

20

Functional screening of genes suppressing TRAIL-induced apoptosis: distinct inhibitory activities of Bcl-XL and Bcl-2

Kim, I-K, Jung, Y-K, Noh, D-Y, Song, Y-S, Choi, C-H, Oh, B-H, Masuda, E S, Jung, Y-K

Journal:

British Journal of Cancer

Year:

2003

Language:

english

File:

PDF, 266 KB

english, 2003

21

684PImpact of adjuvant treatment with nab-paclitaxel and gemcitabine (nab-P+GEM) vs gemcitabine alone (GEM) on health-related quality of life (QoL) in patients (pts) with surgically resected pancreatic adenocarcinoma (PA) in the adjuvant pancreatic adenocarcinoma clinical trial (APACT)

Riess, H, Braverman, J, Reni, M, Dueck, A C, Hendifar, A, Oh, D-Y, Li, C-P, Mercade, T Macarulla, Shah, A, Joshi, N, Botterman, M, Mantovani, E, Lu, B, Tempero, M A

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 112 KB

2019

22

Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy

Lee, D-W, Han, S-W, Lee, H J, Rhee, Y-Y, Bae, J M, Cho, N-Y, Lee, K-H, Kim, T-Y, Oh, D-Y, Im, S-A, Bang, Y-J, Jeong, S-Y, Park, K J, Park, J-G, Kang, G H, Kim, T-Y

Journal:

British Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 239 KB

english, 2013

23

687PEvaluation of minimal important difference (MID) for the European organisation for research and treatment of cancer (EORTC) pancreatic cancer module (PAN26) in patients with surgically resected pancreatic adenocarcinoma

Reni, M, Braverman, J, Hendifar, A, Li, C-P, Macarulla Mercade, T, Oh, D-Y, Riess, H, Tempero, M A, Lu, B, Marcus, J, Joshi, N, Botterman, M, Dueck, A C

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 81 KB

2019

24

Long-term follow-up of bintrafusp alfa, a bifunctional fusion protein targeting TGF-Î² and PD-L1, in patients with pretreated biliary tract cancer

Yoo, C., Oh, D-Y., Choi, H.J., Kudo, M., Ueno, M., Kondo, S., Chen, L-T., Osada, M., Helwig, C., Dussault, I., Ikeda, M.

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 107 KB

2020

25

625PDPembrolizumab for advanced biliary adenocarcinoma: Results from the multicohort, phase II KEYNOTE-158 study

Ueno, M, Chung, H C, Nagrial, A, Marabelle, A, Kelley, R K, Xu, L, Mahoney, J, Pruitt, S K, Oh, D-Y

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 74 KB

english, 2018

26

624PDPreliminary results of a ph2a study to evaluate the clinical efficacy and safety of erdafitinib in Asian patients with biomarker-selected advanced cholangiocarcinoma (CCA)

Chen, Y-Y, Park, J O, Su, W-C, Oh, D-Y, Kim, K-P, Feng, Y-H, Shen, L, Liao, H, Nie, J, Qing, M, Li, J, De Porre, P

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 75 KB

2018

27

Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib

Hammel, P, Kindler, H L, Reni, M, Van Cutsem, E, Macarulla, T, Hall, M J, Park, J O, Hochhauser, D, Arnold, D, Oh, D-Y, Reinacher-Schick, A, Tortora, G, Algül, H, O’Reilly, E M, McGuinness, D, Cui, K

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 1.81 MB

2019

28

757PM7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in Asian patients with pretreated biliary tract cancer: Preliminary results from a phase I trial

Yoo, C, Oh, D-Y, Choi, H J, Kudo, M, Ueno, M, Kondo, S, Chen, L-T, Osada, M, Helwig, C, Dussault, I, Ikeda, M

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 95 KB

english, 2018

29

The beneficial effect of palliative resection in metastatic colorectal cancer

Park, J H, Kim, T-Y, Lee, K-H, Han, S-W, Oh, D-Y, Im, S-A, Kang, G H, Chie, E K, Ha, S W, Jeong, S-Y, Park, K J, Park, J-G, Kim, T-Y

Journal:

British Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 546 KB

english, 2013

30

715PJab1 silencing inhibits proliferation and sensitizes to cisplatin in biliary tract cancer

Kim, J-W., Nam, A-R., Park, J.E., Bang, J-H., Jin, M.H., Oh, D-Y., Bang, Y-J.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 76 KB

english, 2017

31

A phase II/III, randomized, placebo-controlled study of bintrafusp alfa with gemcitabine plus cisplatin as first-line treatment of biliary tract cancer

Oh, D-Y., de Braud, F., Bridgewater, J., Furuse, J., Hsu, C-H., Ikeda, M., Javle, M., Moehler, M., Park, J.O., Shen, L., Yoo, C., Helwig, C., Osada, M., Borad, M.

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 88 KB

2020

32

566PA first-in-human phase I study of GC1118, a novel monoclonal antibody inhibiting epidermal growth factor receptor (EGFR), in patients with colorectal cancer and gastric/GEJ cancer

Oh, D-Y, Lee, K-W, Han, S-W, Kim, J W, Shin, J-W, Jo, S-J, Kim, N H, Woo, A, Won, J, Hahn, S, Lee, H, Kim, W H, Bang, Y-J

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 79 KB

english, 2018

33

789TiPHALO 109-301: Phase III, randomized, double-blind, placebo-controlled study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients with previously untreated hyaluronan (HA)-high stage IV pancreatic ductal adenocarcinoma (PDA)

Van Cutsem, E, Corrie, P G, Ducreux, M P, Sigal, D, Sahai, V, Oh, D-Y, Bullock, A, Bang, Y-J, Baron, A D, Hendifar, A, Li, C-P, Philip, P, Reni, M, Zalupski, M, Zheng, L, Berman, C, Chondros, D, Tempe

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 76 KB

english, 2018

34

190PDResearch-based PAM50 predicts risk of relapse in residual disease after anti-HER2 therapies

Bianchini, G, Parker, J, Carey, L, Perou, C M, Sica, L, Prat, A, Pieńkowski, T, Im, Y-H, Bianchi, G V, Ling-Ming, T, Liu, M-C, Lluch, A, Semiglazov, V, de la Haba-Rodriguez, J, Oh, D-Y, Poirier, B, Pe

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 80 KB

english, 2018

35

693PPOLO: Time to treatment discontinuation and subsequent therapies following maintenance olaparib for patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC)

Van Cutsem, E, Golan, T, Hammel, P, Reni, M, Macarulla, T, Hall, M J, Park, J O, Hochhauser, D, Arnold, D, Oh, D-Y, Reinacher-Schick, A, Tortora, G, Algül, H, O’Reilly, E M, McGuinness, D, Cui, K Y, S

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 94 KB

2019

36

X-ray absorption spectroscopy study on oxygen-deficient hafnium oxide film

Cho, D-Y, Min, C-H, Kim, J-Y, Park, J-H, Oh, S-J, Hwang, C S

Journal:

Journal of Physics Conference Series

Year:

2008

Language:

english

File:

PDF, 613 KB

english, 2008

37

409OLarotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach

Lassen, U N, Albert, C M, Kummar, S, van Tilburg, C M, Dubois, S G, Geoerger, B, Mascarenhas, L, Federman, N, Schilder, R J, Doz, F, Berlin, J D, Oh, D-Y, Bielack, S S, McDermott, R, Tan, D S, Cruicks

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 98 KB

english, 2018

38

69OLarotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach

Tan, D S W, Lassen, U N, Albert, C M, Kummar, S, van Tilburg, C, Dubois, S G, Geoerger, B, Mascarenhas, L, Federman, N, Basu-Mallick, A, Doz, F, Berlin, J D, Oh, D-Y, Bielack, S, McDermott, R, Cruicks

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 93 KB

english, 2018

39

816PThe analysis of T cell subsets and clinical efficacy of immune checkpoint blockades in patients with advanced gastric cancer using multiplex immunohistochemistry

Kim, T-Y, Lee, D-W, Oh, D-Y, Kwak, Y, Lee, H S, Kim, W-H, Bang, Y-J

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 77 KB

2019

40

211TiPHALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin + gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) + CIS + GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer

Oh, D-Y, Park, J-O, Charoentum, C, Stein, S, Noel, M, Chung, V, Wu, W, Alton, R, Muhsin, M, Javle, M, Abou-Alfa, G K, Borad, M J

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 81 KB

english, 2018

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски